Cite
Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life
MLA
Mirochnick, Mark, et al. “Safety and Pharmacokinetics of Nelfinavir Coadministered with Zidovudine and Lamivudine in Infants during the First 6 Weeks of Life.” Journal of Acquired Immune Deficiency Syndromes (1999), vol. 39, no. 2, June 2005, p. 189. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.135195561&authtype=sso&custid=ns315887.
APA
Mirochnick, M., Acevedo, M., Holland, D., Connor, J., Watts, H., Stek, A., Keller Margaret, Capparelli, E., Huang, S., Hughes, M., Bryson, Y., & Mofenson, L. (2005). Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life. Journal of Acquired Immune Deficiency Syndromes (1999), 39(2), 189.
Chicago
Mirochnick, Mark, Midnela Acevedo, Diane Holland, James Connor, Heather Watts, Alice Stek, Keller Margaret, et al. 2005. “Safety and Pharmacokinetics of Nelfinavir Coadministered with Zidovudine and Lamivudine in Infants during the First 6 Weeks of Life.” Journal of Acquired Immune Deficiency Syndromes (1999) 39 (2): 189. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.135195561&authtype=sso&custid=ns315887.